CL1: The First Commercial Biological Computer Powered by Human Neurons
CL1
Introduction
The world’s first commercial biological computer, CL1, is now a reality. Developed by Cortical Labs, this groundbreaking innovation processes information using real human neurons cultivated in a lab. The CL1 promises to be more adaptive, sustainable, and energy-efficient than traditional silicon-based chips used in AI systems today.
1. How CL1 Works: Biological Computing in Action
The CL1 integrates living neurons with hardware components to create a Synthetic Biological Intelligence (SBI) system.
Uses human neural cells grown in a lab to form autonomous connections.
Neurons are kept alive in a nutrient-rich solution for up to six months.
The microprocessor interfaces with neurons, sending and receiving electrical impulses for bidirectional communication.
Powered by biOS, a unique operating system that simulates a virtual environment where neurons respond and adapt.
2. Efficiency and Energy Consumption
One of CL1’s biggest advantages is its energy efficiency, which surpasses conventional AI models.
Consumes only 850 to 1,000 watts per rack, compared to 3.7 million watts per year per GPU in traditional AI data centers.
Requires minimal resources while delivering longer research cycles.
Enables sustainable AI development with significantly lower power usage.
3. Presentation at Mobile World Congress 2025
The CL1 was officially unveiled at MWC 2025 in Barcelona, marking the culmination of six years of research by Cortical Labs.
CEO Hon Weng Chong emphasized the goal of democratizing biological computing.
CL1 aims to make advanced AI research accessible without requiring specialized hardware or software.
4. CL1’s Research Applications
Unlike traditional computers, CL1 is not designed for everyday tasks but serves as a powerful research tool.
Helps scientists understand how neurons process information.
Allows real-time study of learning and memory formation.
Provides new insights into neurodegenerative diseases and cognitive functions.
Eliminates the need for animal testing, offering a more ethical research alternative.
5. Commercial Availability and Pricing
Cortical Labs plans to launch CL1 for commercial use in mid-2025.
The biological computer will be available for direct purchase at €32,500.
Researchers can also opt for WaaS (Wetware as a Service), enabling access to CL1 chips via the cloud.
This platform will allow scientists and developers worldwide to experiment with biological computing.
6. The Future of Biocomputing
The introduction of CL1 signals a new era of computing, blending biology with technology.
Future advancements could lead to AI models that learn and adapt more like the human brain.
This innovation paves the way for more efficient, sustainable, and intelligent computing systems.
As research progresses, biological computers could complement or even surpass traditional silicon-based computing.
Conclusion
CL1 represents a revolutionary step in computing, combining human neurons with advanced AI processing. With its energy efficiency, adaptability, and research potential, it has the power to reshape AI development and neuroscience. As Cortical Labs prepares to bring this technology to the world, the possibilities for scientific breakthroughs are limitless.
Frequently Asked Questions (FAQs)
1. What is CL1, and how does it work?
CL1 is the first commercial biological computer that processes information using living human neurons cultivated in a lab. It integrates biological and digital components for advanced AI research.
2. How does CL1 compare to traditional AI systems?
Unlike silicon-based AI models, CL1 adapts to its environment, forms autonomous neuronal connections, and consumes significantly less energy.
3. What are the potential applications of CL1?
CL1 is primarily a research tool used to study neural processing, learning, memory, and neurodegenerative diseases.
4. How much does CL1 cost?
The CL1 will be available for €32,500, with an option to access it remotely via Wetware as a Service (WaaS).
5. When will CL1 be available for purchase?
Cortical Labs plans to commercially launch CL1 in mid-2025, making it accessible to researchers worldwide.